Although bile acid synthesis was increased in COVID-19 patients, in CCL2+ T cells and Group 2 macrophages, compared with moderate patients, the metabolic responses related to bile acid synthesis were almost all downregulated in severe patients (Figure 5A). The gene discussed is CCL2; the disease is COVID-19.